stakddek; Now this is something worth more to me than some superflous post about another forensics conference where we are mentioned.
The fact that we are working in conjuntion w/ Affy is saying something huge. I firmly believe that Affy's chip will be the choice for personalized medicine. I also HOPE that DnaPrint's ADMIXMAP tm will also be included in that chip for use, if that is the form in which things take place. As long as we stay seperate from that which is forming, we will ultimately lose out. I feel we much have some point of conjunction w/ the synergy that's occuring. Perhaps I have this wrong and going it alone w/ BioFrontera is the approach, but so far I haven't seen where we are benefitting from it.
I have been told to tame it down on Richard Gabriel by some of the posters I do care for here. Well, sorry, but I am going to take a divergent path. I don't see where he and his wife has brought to fruition anything as of yet. I am not saying that there aren't things going on that may be, but nothing has been.
Miss Scarlet, if you are reading this post, I applaud your continuing stability of presence on the board. My growing dissapointment w/ management is apparent, I acknowledge. As this is a community board that accepts and allows divergence of opinion, please don't be offended if I prompt participation on managements present poor proffering in a PR. I think it is quite appropriate for Ann to dissemble information that is old, but pertainent, yet I find that for the BOD to be paying for something as inane as participation in a panel, once again preposterous. Yes, it was I who refered to Richlip and Miss Manglemanagement earlier this year. Sorry to say that I intend to start in again if all we end up with is further non-performance spending. I consider it my right as a longterm investor who is now eyeballing the costs involved in their involvement. It is their responsibility to bring things to fruition and increase investors value, not Dr. Frudakis's. Todate, I have only been offered the promise of potential w/ little of substance on which to hang my hat. I see alot of movement and as some have indicated, no revenue supporting contracts or acquisitions. I am sorry if this seems to be directed at you, Miss Scarlet, though posted to stacddek. It really has nothing to do with you in particular, though We did sort of open the door in this discussion.
I want
News 
Market Data 
Discover 
AI
